World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
151 Emergent BioSolutions Inc. $667.4 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
152 Alar Pharmaceuticals, Inc. $658.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
153 Swedencare AB $657.1 M Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
154 Nihon Chouzai Co.,Ltd. $653.2 M

(July 1, 2025)

 Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
155 Yabao Pharmaceutical Group Co. Ltd $649.1 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
156 Tianjin Tianyao Pharmaceuticals Co. Ltd $644.4 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
157 TTY Biopharm Company Ltd $641.3 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
158 Ningbo Menovo Pharmaceutical Co. Ltd $636.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
159 Zhejiang Starry Pharmaceutical Co. Ltd $612.4 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
160 TerrAscend Corp $607.4 M

(July 1, 2023)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
161 Pharmanutra S.p.A. $607.1 M Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
162 Grape King Bio Ltd $602.9 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
163 Boiron SA $601.7 M France French Healthcare French Drug Manufacturers—Specialty & Generic
164 Organogenesis Holdings Inc. $588.2 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
165 Zeria Pharmaceutical Co. Ltd $577.8 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
166 KYORIN Holdings, Inc. $555.4 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
167 Hainan Poly Pharm. Co. Ltd $550.9 M

(Jan. 1, 2025)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
168 Henan Taloph Pharmaceutical Stock Co.,Ltd $548.9 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
169 Huaren Pharmaceutical Co. Ltd $544.3 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
170 Wuhan Hiteck Biological Pharma Co. Ltd $543.7 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
171 Synmosa Biopharma Corp $526.8 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
172 Elite Pharmaceuticals, Inc. $526.6 M United States US Healthcare US Drug Manufacturers—Specialty & Generic
173 Nanjing Well Pharmaceutical Group Co.,Ltd. $520.3 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
174 Zhejiang Cheng Yi Pharmaceutical Co. Ltd $506.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
175 Baotou Dongbao Bio-Tech Co.,Ltd $495.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
176 YungShin Global Holding Corp $485.5 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
177 Lionco Pharmaceutical Group Co. Ltd $483.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
178 Zhejiang Shengda Bio-Pharm Co. Ltd $478.6 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
179 Guizhou Yibai Pharmaceutical Co. Ltd $459.4 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
180 Handa Pharmaceuticals, Inc. $459.4 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

151. Emergent BioSolutions Inc.

Company Profile: Emergent BioSolutions Inc.
Market Cap (USD): $667.4 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

152. Alar Pharmaceuticals, Inc.

Company Profile: Alar Pharmaceuticals, Inc.
Market Cap (USD): $658.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

153. Swedencare AB

Company Profile: Swedencare AB
Market Cap (USD): $657.1 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

154. Nihon Chouzai Co.,Ltd.

Company Profile: Nihon Chouzai Co.,Ltd.
Market Cap (USD): $653.2 M (July 1, 2025)
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

155. Yabao Pharmaceutical Group Co. Ltd

Company Profile: Yabao Pharmaceutical Group Co. Ltd
Market Cap (USD): $649.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

156. Tianjin Tianyao Pharmaceuticals Co. Ltd

Company Profile: Tianjin Tianyao Pharmaceuticals Co. Ltd
Market Cap (USD): $644.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

157. TTY Biopharm Company Ltd

Company Profile: TTY Biopharm Company Ltd
Market Cap (USD): $641.3 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

158. Ningbo Menovo Pharmaceutical Co. Ltd

Company Profile: Ningbo Menovo Pharmaceutical Co. Ltd
Market Cap (USD): $636.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

159. Zhejiang Starry Pharmaceutical Co. Ltd

Company Profile: Zhejiang Starry Pharmaceutical Co. Ltd
Market Cap (USD): $612.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

160. TerrAscend Corp

Company Profile: TerrAscend Corp
Market Cap (USD): $607.4 M (July 1, 2023)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

161. Pharmanutra S.p.A.

Company Profile: Pharmanutra S.p.A.
Market Cap (USD): $607.1 M
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

162. Grape King Bio Ltd

Company Profile: Grape King Bio Ltd
Market Cap (USD): $602.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

163. Boiron SA

Company Profile: Boiron SA
Market Cap (USD): $601.7 M
Country: France
Sector: French Healthcare
Industry: French Drug Manufacturers—Specialty & Generic

164. Organogenesis Holdings Inc.

Company Profile: Organogenesis Holdings Inc.
Market Cap (USD): $588.2 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

165. Zeria Pharmaceutical Co. Ltd

Company Profile: Zeria Pharmaceutical Co. Ltd
Market Cap (USD): $577.8 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

166. KYORIN Holdings, Inc.

Company Profile: KYORIN Holdings, Inc.
Market Cap (USD): $555.4 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

167. Hainan Poly Pharm. Co. Ltd

Company Profile: Hainan Poly Pharm. Co. Ltd
Market Cap (USD): $550.9 M (Jan. 1, 2025)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

168. Henan Taloph Pharmaceutical Stock Co.,Ltd

Company Profile: Henan Taloph Pharmaceutical Stock Co.,Ltd
Market Cap (USD): $548.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

169. Huaren Pharmaceutical Co. Ltd

Company Profile: Huaren Pharmaceutical Co. Ltd
Market Cap (USD): $544.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

170. Wuhan Hiteck Biological Pharma Co. Ltd

Company Profile: Wuhan Hiteck Biological Pharma Co. Ltd
Market Cap (USD): $543.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

171. Synmosa Biopharma Corp

Company Profile: Synmosa Biopharma Corp
Market Cap (USD): $526.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

172. Elite Pharmaceuticals, Inc.

Company Profile: Elite Pharmaceuticals, Inc.
Market Cap (USD): $526.6 M
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

173. Nanjing Well Pharmaceutical Group Co.,Ltd.

Company Profile: Nanjing Well Pharmaceutical Group Co.,Ltd.
Market Cap (USD): $520.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

174. Zhejiang Cheng Yi Pharmaceutical Co. Ltd

Company Profile: Zhejiang Cheng Yi Pharmaceutical Co. Ltd
Market Cap (USD): $506.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

175. Baotou Dongbao Bio-Tech Co.,Ltd

Company Profile: Baotou Dongbao Bio-Tech Co.,Ltd
Market Cap (USD): $495.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

176. YungShin Global Holding Corp

Company Profile: YungShin Global Holding Corp
Market Cap (USD): $485.5 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

177. Lionco Pharmaceutical Group Co. Ltd

Company Profile: Lionco Pharmaceutical Group Co. Ltd
Market Cap (USD): $483.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

178. Zhejiang Shengda Bio-Pharm Co. Ltd

Company Profile: Zhejiang Shengda Bio-Pharm Co. Ltd
Market Cap (USD): $478.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

179. Guizhou Yibai Pharmaceutical Co. Ltd

Company Profile: Guizhou Yibai Pharmaceutical Co. Ltd
Market Cap (USD): $459.4 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

180. Handa Pharmaceuticals, Inc.

Company Profile: Handa Pharmaceuticals, Inc.
Market Cap (USD): $459.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

Stay in touch